Business Wire

Octave MSDA Test Gains NY State Certification, Expanding Access Nationwide

The Only Clinically Validated Multiple Sclerosis Multi-Analyte Test Proven to Deliver Clinically Meaningful Insights Is Now Available In All 50 States MENLO PARK, Calif.--(BUSINESS WIRE)--Octave® ...
Business Wire

Octave Bioscience Awarded Valhalla Foundation Grant to Accelerate Development of the First MS Disease Progression Test

MENLO PARK, Calif.--(BUSINESS WIRE)--Octave Bioscience, Inc., a commercial-stage precision care company pioneering biomarker-driven solutions for multiple sclerosis (MS) and other neurodegenerative ...
Nasdaq

Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the ...

Collaboration enables patients to access the Octave MSDA test at Quest’s approximately 7,000 patient access sites across the U.S. and establishes a pathway to introduce additional tests from Octave’s ...
Morningstar

Octave MSDA Test Gains NY State Certification, Expanding Access Nationwide

Octave® Bioscience, Inc., a leading precision care company that delivers a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, announced today the Octave Multiple ...